Application of berberine in the preparation of drugs for preventing and treating rheumatoid arthritis
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of berberine, arthritis, applied in the field of traditional Chinese medicine
Inactive Publication Date: 2012-02-01
SECOND MILITARY MEDICAL UNIV OF THE PEOPLES LIBERATION ARMY
View PDF2 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
Berberine, also known as berberine, is an isoquinoline alkaloid with antibacterial, anti-tuberculosis, anti-Leptospira, antiprotozoal, sedative, antipyretic, blood pressure-lowering, and choleretic effects. Has been reported for the treatment of rheumatoid arthritis
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0017] Embodiment 1 berberine animal efficacy test
[0018] 1. Experimental materials
[0019] Drugs and Reagents
[0020] Berberine: purchased from China National Institute of Pharmaceutical and Biological Products, dissolved in 3‰ CMC-Na solution to a 1 mg / ml solution. Different volumes were intraperitoneally injected according to the body weight of the animals. Chicken type II collagen (CII): Chondrex, Redmond, WA 98052, USA; Incomplete Freund's Adjuvant (IFA) Difco Laboratories, Detroit, MI; Phosphate buffered saline (PBS): self-prepared by our laboratory, in 800ml Dissolve 8gNaCl, 0.2g KCl, 1.44g Na in distilled water 2 HPO 4 and 0.24g KH 2 PO 4 . Use hydrochloric acid to adjust the pH to 7.4, add water to make up to 1L, and use after filter sterilization; DMSO dimethyl sulfoxide (Dimethylsulfoxide, DMSO): a product of Sigma Company; 1640 medium: Gino Biomedical Technology Co., Ltd.; Calf Serum: Minhai Biological Co., Ltd.; 96-well flat bottom plate, CORNING; 70 μ...
Embodiment 2
[0054] Tablets: Berberine 20g
[0055] Lactose 177g
[0056] Cornstarch 50g
[0057] Magnesium Stearate 3g
[0058] Preparation method: mix berberine, lactose and starch, moisten evenly with water, sieve the wet mixture and dry it, then sieve it, add magnesium stearate, then press the mixture into tablets, each tablet weighs 250mg, Berberis The alkali content is 20mg.
Embodiment 3
[0060] Ampoule: Berberine 10g
[0061] Sodium chloride 9g
[0062] Preparation method: dissolve berberine and sodium chloride in an appropriate amount of water for injection, filter the resulting solution, and fill it into ampoules under aseptic conditions, each containing 10 mg of berberine.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention provides the application of berberine in the preparation of medicines for preventing and treating rheumatoid arthritis. The invention adopts the berberine to carry out the animal efficacy test, and the result shows that the berberine can inhibit the clinical onset of collagen-induced arthritis, and obviously inhibit the severity and incidence rate of the onset. And can down-regulate tumor necrosis factor α, interleukin 17, interferon γ in spleen cell supernatant, inhibit the secretion of pro-inflammatory cytokines TNF-α, IFN-γ and IL-17, so as to prepare drugs for preventing and treating rheumatoid arthritis, It has great clinical application value. The medicine is a pharmaceutical composition made of berberine as an active ingredient and conventional pharmaceutical excipients, including tablets, dispersible tablets, buccal tablets, orally disintegrating tablets, sustained-release tablets, capsules, soft capsules, dropping pills, Granules, injections, powder injections or aerosols.
Description
technical field [0001] The invention relates to traditional Chinese medicines, in particular to the application of berberine in the preparation of medicines for preventing and treating rheumatoid arthritis. Background technique [0002] Rheumatoid arthritis (Rheumatoid Arthritis, RA) is a chronic systemic inflammatory disease of unknown etiology, with chronic, symmetrical, polysynovial arthritis and extra-articular lesions as the main clinical manifestations, belonging to autoimmune inflammatory diseases disease. The disease is prone to occur in small joints such as hands, wrists, and feet, and recurs in a symmetrical distribution. In the early stage, joints are red, swollen, hot, painful, and dysfunctional. In the late stage, joints may be stiff and deformed in varying degrees, accompanied by atrophy of bones and skeletal muscles, which is very easy to cause disability. From the perspective of pathological changes, rheumatoid arthritis is a disease that mainly involves th...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/4375A61P19/02A61P29/00
Inventor 胡振林张卫东苏娟柳润辉沈云亨李慧梁徐希科焦晴晴
Owner SECOND MILITARY MEDICAL UNIV OF THE PEOPLES LIBERATION ARMY
Login to view more 
Login to view more